Literature DB >> 20739533

Compromised spindle assembly checkpoint due to altered expression of Ubch10 and Cdc20 in human papillomavirus type 16 E6- and E7-expressing keratinocytes.

Daksha Patel1, Dennis J McCance.   

Abstract

Cells expressing human papillomavirus type 16 (HPV-16) E6 and E7 proteins exhibit deregulation of G2/M genes, allowing bypass of DNA damage arrest signals. Normally, cells with DNA damage that override the G2 damage checkpoint would precociously enter mitosis and ultimately face mitotic catastrophe and apoptotic cell death. However, E6/E7-expressing cells (E6/E7 cells) have the ability to enter and exit mitosis in the presence of DNA damage and continue with the next round of the cell cycle. Little is known about the mechanism that allows these cells to gain entry into and exit from mitosis. Here, we show that in the presence of DNA damage, E6/E7 cells have elevated levels of cyclin B, which would allow entry into mitosis. Also, as required for exit from mitosis, cyclin B is degraded in these cells, permitting initiation of the next round of DNA synthesis and cell cycle progression. Proteasomal degradation of cyclin B by anaphase-promoting complex/cyclosome (APC/C) is, in part, due to elevated levels of the E2-conjugating enzyme, Ubch10, and the substrate recognition protein, Cdc20, of APC/C. Also, in E6/E7 cells with DNA damage, while Cdc20 is complexed with BubR1, indicating an active checkpoint, it is also present in complexes free of BubR1, presumably allowing APC/C activity and slippage through the checkpoint.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739533      PMCID: PMC2953194          DOI: 10.1128/JVI.00259-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein.

Authors:  J R Basile; V Zacny; K Münger
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

3.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

Authors:  Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

4.  Cell cycle-regulated proteolysis of mitotic target proteins.

Authors:  H Bastians; L M Topper; G L Gorbsky; J V Ruderman
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

5.  Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins.

Authors:  Daksha Patel; Angela Incassati; Nancy Wang; Dennis J McCance
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

6.  Mad2 prolongs DNA damage checkpoint arrest caused by a double-strand break via a centromere-dependent mechanism.

Authors:  Farokh Dotiwala; Jacob C Harrison; Suvi Jain; Neal Sugawara; James E Haber
Journal:  Curr Biol       Date:  2010-01-21       Impact factor: 10.834

7.  Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.

Authors:  Baojin Fu; Jesse Quintero; Carl C Baker
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

Review 8.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

9.  Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2.

Authors:  V Sudakin; G K Chan; T J Yen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

10.  Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.

Authors:  Alexei Mikhailov; Mio Shinohara; Conly L Rieder
Journal:  J Cell Biol       Date:  2004-08-09       Impact factor: 10.539

View more
  12 in total

Review 1.  How virus persistence can initiate the tumorigenesis process.

Authors:  Simone Avanzi; Gualtiero Alvisi; Alessandro Ripalti
Journal:  World J Virol       Date:  2013-05-12

2.  Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy.

Authors:  Ida Perrotta; Leonardo Bruno; Lorenza Maltese; Emilio Russo; Annalidia Donato; Giuseppe Donato
Journal:  J Histochem Cytochem       Date:  2012-03-02       Impact factor: 2.479

3.  Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Authors:  Nicholas J Genovese; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 4.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

Authors:  M Matsuoka; K-T Jeang
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

5.  Stabilization of p27Kip1/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.

Authors:  Elizabeth A Whitcomb; Yien Che Tsai; Johnvesly Basappa; Ke Liu; Aurélie K Le Feuvre; Allan M Weissman; Allen Taylor
Journal:  FASEB J       Date:  2018-08-16       Impact factor: 5.191

Review 6.  Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.

Authors:  Zhonglin Hao; Hui Zhang; John Cowell
Journal:  Tumour Biol       Date:  2011-12-16

7.  Human papillomavirus E7 induces rereplication in response to DNA damage.

Authors:  Xueli Fan; Yingwang Liu; Susan A Heilman; Jason J Chen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

8.  High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.

Authors:  Zhihua Shen; Xiaofan Jiang; Chao Zeng; Shaojiang Zheng; Botao Luo; Yumei Zeng; Ranran Ding; Hanguo Jiang; Qiyi He; Junli Guo; Wei Jie
Journal:  BMC Cancer       Date:  2013-04-15       Impact factor: 4.430

9.  Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.

Authors:  Ana María Espinosa; Ana Alfaro; Edgar Roman-Basaure; Mariano Guardado-Estrada; Ícela Palma; Cyntia Serralde; Ingrid Medina; Eligia Juárez; Miriam Bermúdez; Edna Márquez; Manuel Borges-Ibáñez; Sergio Muñoz-Cortez; Avissai Alcántara-Vázquez; Patricia Alonso; José Curiel-Valdez; Susana Kofman; Nicolas Villegas; Jaime Berumen
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.

Authors:  Ingrid Medina-Martinez; Valeria Barrón; Edgar Roman-Bassaure; Eligia Juárez-Torres; Mariano Guardado-Estrada; Ana María Espinosa; Miriam Bermudez; Fernando Fernández; Carlos Venegas-Vega; Lorena Orozco; Edgar Zenteno; Susana Kofman; Jaime Berumen
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.